{"nct_id":"NCT01234857","title":"A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2010-09-17","start_date_type":"ACTUAL","primary_completion_date":"2013-10-15","primary_completion_date_type":"ACTUAL","completion_date":"2013-10-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}